Self-support protocol
PCOS protocol harmonizing reproductive hormone teams. Balance metabolism through insulin and androgen regulation.
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by hyperandrogenism, ovulatory dysfunction and often insulin resistance. It reflects dysregulation across hypothalamic–pituitary–ovarian (HPO) and metabolic axes rather than isolated ovarian pathology.
In PCOS, GnRH pulses from the hypothalamus and LH/FSH secretion from the pituitary are altered, often with an increased LH:FSH ratio. Elevated LH stimulates theca cells in the ovary to produce excess androgens (testosterone, androstenedione).
Granulosa cells may exhibit impaired aromatase activity, limiting conversion of androgens to estrogens. Follicular development stalls, leading to multiple small antral follicles and chronic anovulation.
Many individuals with PCOS display peripheral insulin resistance, with compensatory hyperinsulinemia. Insulin acts synergistically with LH on theca cells, further boosting androgen production. Adipose tissue dysfunction, inflammatory cytokines and altered adipokine profiles (leptin, adiponectin) contribute to metabolic risk.
Elevated androgens drive hirsutism, acne and androgenic alopecia. In the skin and hair follicles, androgen receptors mediate increased sebum production and terminal hair growth. In ovarian tissue, hyperandrogenism interferes with normal folliculogenesis and ovulation, contributing to subfertility.
PCOS is associated with increased risk of type 2 diabetes, dyslipidemia, hypertension and possibly endometrial hyperplasia due to unopposed estrogen exposure. Mood and anxiety disorders are also more prevalent, highlighting the need for integrated care.
PCOS thus represents a network‑level disturbance of endocrine and metabolic regulation. Multimodal treatment can meaningfully modify both symptoms and long‑term health risks.
Polycystic ovary syndrome (PCOS) involves hormonal imbalance where your ovaries produce excess androgens (male hormones), disrupting ovulation and causing metabolic dysfunction. Your hypothalamus releases GnRH in rapid pulses, causing your pituitary to overproduce LH relative to FSH. High LH stimulates your ovarian theca cells to produce excessive testosterone and androstenedione. Meanwhile, insulin resistance (often present in PCOS) causes your pancreas to produce excess insulin, which further stimulates androgen production and prevents your liver from producing sex hormone-binding globulin that would normally bind excess testosterone. This creates a cycle: high insulin promotes androgen production, high androgens worsen insulin resistance. Your ovarian follicles start developing but don't mature properly, forming small cysts. Excess androgens cause hirsutism (excess hair), acne, and male-pattern baldness. Lack of ovulation means your endometrium isn't regularly shed, increasing endometrial cancer risk. The 'organism as team' framework helps because your endocrine and metabolic systems are caught in a feedback loop—each trying to respond to abnormal signals, creating a self-reinforcing pattern. Your ovaries are responding to hormonal commands they receive, your pancreas is fighting insulin resistance, your pituitary is trying to stimulate ovulation. Supporting your team means breaking the cycle: insulin-sensitizing interventions (diet, exercise, sometimes metformin) to reduce insulin, which decreases androgen production; sometimes medications to block androgens or regulate cycles; stress management since cortisol worsens insulin resistance. Your organism's systems can rebalance with coordinated support. ⚕️ This protocol does not replace professional consultation.